These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 10720890

  • 1. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS.
    Nephron; 2000 Mar; 84(3):211-7. PubMed ID: 10720890
    [Abstract] [Full Text] [Related]

  • 2. Serum antioxidant activity in diabetes mellitus.
    Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH.
    Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
    [Abstract] [Full Text] [Related]

  • 3. Carbamylation inhibits the ferroxidase activity of caeruloplasmin.
    Roxborough HE, Millar CA, McEneny J, Young IS.
    Biochem Biophys Res Commun; 1995 Sep 25; 214(3):1073-8. PubMed ID: 7575512
    [Abstract] [Full Text] [Related]

  • 4. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ, Bomford A, Halliwell B.
    Free Radic Res Commun; 1989 Sep 25; 7(1):55-62. PubMed ID: 2806955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation.
    Gutteridge JM.
    FEBS Lett; 1983 Jun 27; 157(1):37-40. PubMed ID: 6862018
    [Abstract] [Full Text] [Related]

  • 8. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin.
    Powers HJ, Loban A, Silvers K, Gibson AT.
    Free Radic Res; 1995 Jan 27; 22(1):57-65. PubMed ID: 7889148
    [Abstract] [Full Text] [Related]

  • 9. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
    Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW.
    J Lab Clin Med; 1994 Aug 27; 124(2):263-73. PubMed ID: 8051491
    [Abstract] [Full Text] [Related]

  • 10. Plasma glutathione peroxidase activity is reduced in haemodialysis patients.
    Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS.
    Nephron; 1999 Aug 27; 81(3):278-83. PubMed ID: 10050081
    [Abstract] [Full Text] [Related]

  • 11. Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis.
    Gutteridge JM.
    Biochim Biophys Acta; 1986 Jan 30; 869(2):119-27. PubMed ID: 3942755
    [Abstract] [Full Text] [Related]

  • 12. Ferroxidase and ascorbate oxidase activities of caeruloplasmin in synovial fluid from rheumatoid patients.
    Blake DR, Blann A, Bacon PA, Farr M, Gutteridge JM, Halliwell B.
    Clin Sci (Lond); 1983 May 30; 64(5):551-3. PubMed ID: 6403279
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Caeruloplasmin: a plasma protein, enzyme, and antioxidant.
    Gutteridge JM.
    Ann Clin Biochem; 1978 Nov 30; 15(6):293-6. PubMed ID: 736489
    [Abstract] [Full Text] [Related]

  • 15. Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major.
    Awadallah SM, Nimer NA, Atoum MF, Saleh SA.
    Clin Chim Acta; 2011 May 12; 412(11-12):975-9. PubMed ID: 21315066
    [Abstract] [Full Text] [Related]

  • 16. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
    Wolf TL, Kotun J, Meador-Woodruff JH.
    Schizophr Res; 2006 Sep 12; 86(1-3):167-71. PubMed ID: 16842975
    [Abstract] [Full Text] [Related]

  • 17. The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper.
    Gutteridge JM, Winyard PG, Blake DR, Lunec J, Brailsford S, Halliwell B.
    Biochem J; 1985 Sep 01; 230(2):517-23. PubMed ID: 4052055
    [Abstract] [Full Text] [Related]

  • 18. Serum ultrafiltrable copper, total copper and caeruloplasmin concentrations in gynaecological carcinomas.
    Chan A, Wong F, Arumanayagam M.
    Ann Clin Biochem; 1993 Nov 01; 30 ( Pt 6)():545-9. PubMed ID: 8304722
    [Abstract] [Full Text] [Related]

  • 19. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis.
    Swain JA, Darley-Usmar V, Gutteridge JM.
    FEBS Lett; 1994 Mar 28; 342(1):49-52. PubMed ID: 8143848
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.